From: Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France
2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | Mean | SD | N | Mean | SD | N | Mean | SD | N | Mean | SD | N | Mean | SD | N | Mean | SD | |
Patients with Normal Renal Function | ||||||||||||||||||
Monotherapy | 5,507 | 2,703 | 3,333 | 5,543 | 2,711 | 3,407 | 5,682 | 2,821 | 3,542 | 5,921 | 2,971 | 3,916 | 5,538 | 2,980 | 3,876 | 4,353 | 3,017 | 3,829 |
Double therapy | 2,324 | 2,884 | 3,113 | 2,587 | 2,935 | 3,206 | 2,762 | 3,095 | 3,622 | 2,839 | 3,125 | 3,611 | 2,786 | 3,171 | 3,861 | 2,503 | 3,308 | 4,045 |
Triple therapy | 328 | 3,473 | 3,121 | 406 | 3,295 | 3,013 | 505 | 3,313 | 2,938 | 587 | 3,180 | 3,011 | 658 | 3,264 | 3,312 | 728 | 3,609 | 3,801 |
Insulin therapy | 898 | 6,759 | 5,203 | 1,029 | 6,800 | 5,192 | 1,150 | 7,063 | 5,573 | 1,214 | 7,058 | 5,903 | 1,256 | 7,228 | 5,658 | 1,032 | 7,398 | 5,487 |
Non diabetic patients | 27,389 | 1,715 | 2,914 | 28,962 | 1,767 | 3,060 | 30,618 | 1,866 | 3,261 | 32,103 | 1,994 | 3,475 | 31,128 | 2,150 | 3,979 | 26,253 | 2,166 | 4,102 |
Patients with Declining Renal Function | ||||||||||||||||||
Monotherapy | 282 | 4,148 | 4,258 | 339 | 4,267 | 4,426 | 393 | 4,396 | 4,811 | 465 | 4,897 | 6,427 | 518 | 4,149 | 4,637 | 411 | 4,226 | 5,369 |
Double therapy | 157 | 3,773 | 3,144 | 228 | 3,603 | 3,628 | 266 | 3,667 | 3,257 | 308 | 3,892 | 4,004 | 310 | 3,891 | 4,623 | 267 | 4,159 | 5,268 |
Triple therapy | 27 | 4,244 | 3,641 | 41 | 3,105 | 1,617 | 45 | 4,052 | 3,396 | 69 | 4,203 | 4,411 | 71 | 3,387 | 3,027 | 78 | 4,032 | 4,329 |
Insulin therapy | 136 | 10,772 | 9,335 | 188 | 10,227 | 8,882 | 240 | 10,644 | 10,731 | 294 | 10,499 | 10,185 | 359 | 11,155 | 11,188 | 267 | 11,344 | 11,185 |